Suppr超能文献

评价新生儿和儿科万古霉素药代动力学模型以及在大型多中心数据集中介导成熟和血清肌酐协变量的影响。

Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set.

机构信息

InsightRX, 548 Market St. #88083, San Francisco, CA, 94104, USA.

Department of Pediatrics, Stanford University, Stanford, CA, USA.

出版信息

Clin Pharmacokinet. 2023 Jan;62(1):67-76. doi: 10.1007/s40262-022-01185-4. Epub 2022 Nov 21.

Abstract

BACKGROUND AND OBJECTIVE

Infants and neonates present a clinical challenge for dosing drugs with high interindividual variability due to these patients' rapid growth and the interplay between maturation and organ function. Model-informed precision dosing (MIPD), which can account for interindividual variability via patient characteristics and Bayesian forecasting, promises to improve individualized dosing strategies in this complex population. Here, we assess the predictive performance of published population pharmacokinetic models describing vancomycin in neonates and infants, and analyze the robustness of these models in the face of clinical uncertainty surrounding covariate values.

METHODS

The predictive precision and bias of nine pharmacokinetic models were compared in a large multi-site data set (N = 2061 patients, 5794 drug levels, 28 institutions) of patients aged 0-365 days. The robustness of model predictions to errors in serum creatinine measurements and gestational age was assessed by using recorded values or by replacing covariate values with 0.3, 0.5 or 0.8 mg/dL or with 40 weeks, respectively.

RESULTS

Of the nine models, two models (Dao and Jacqz-Aigrain) resulted in predicted concentrations within 2.5 mg/L or 15% of the measured values for at least 60% of population predictions. Within individual models, predictive performance often 2 differed in neonates (0-4 weeks) versus older infants (15-52 weeks). For preterm neonates, imputing gestational age as 40 weeks reduced the accuracy of model predictions. Measured values of serum creatinine improved model predictions compared to using imputed values even in neonates ≤1 week of age.

CONCLUSIONS

Several available pharmacokinetic models are suitable for MIPD in infants and neonates. Availability and accuracy of model covariates for patients will be important for guiding dose decision-making.

摘要

背景与目的

由于这些患者的快速生长以及成熟度和器官功能之间的相互作用,婴儿和新生儿在药物剂量方面具有很大的个体间变异性,这对临床治疗构成了挑战。模型指导的精准给药(MIPD)可以通过患者特征和贝叶斯预测来考虑个体间变异性,有望改善这一复杂人群的个体化给药策略。在此,我们评估了描述万古霉素在新生儿和婴儿中的已发表群体药代动力学模型的预测性能,并分析了这些模型在面对围绕协变量值的临床不确定性时的稳健性。

方法

在一个大型多中心数据集中(N = 2061 例患者,5794 个药物水平,28 家机构),比较了 9 种药代动力学模型的预测精度和偏差。通过使用记录值或分别用 0.3、0.5 或 0.8 mg/dL 或 40 周替代协变量值,评估了模型预测对血清肌酐测量值和胎龄误差的稳健性。

结果

在所研究的 9 种模型中,有两种模型(Dao 和 Jacqz-Aigrain)至少有 60%的预测结果的预测浓度在实测值的 2.5 mg/L 或 15%范围内。在单个模型中,预测性能在新生儿(0-4 周)和较大婴儿(15-52 周)之间通常存在差异。对于早产儿,将胎龄估计为 40 周会降低模型预测的准确性。与使用估算值相比,测量的血清肌酐值甚至在出生后 1 周以内的新生儿中也能改善模型预测。

结论

有几种可用的药代动力学模型适用于婴儿和新生儿的 MIPD。患者模型协变量的可用性和准确性对于指导剂量决策将很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d7/9898357/0d9e584b7ee1/40262_2022_1185_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验